The effect of epidemics on pregnant women and newborns has often been neglected, so what do we know about the effects of COVID-19 in pregnancy and newborns?
As vaccines and other treatments are developed, should pregnant women also be included in clinical trials?
In low- and middle-income countries, disruption of essential maternity and newborn services may erode many of the gains made in maternal and child health over the past two decades.
In the era of Covid-19, the imperative to manage our finite healthcare resources has become greater than ever. RCH became a Choosing Wisely Champion Hospital in 2019 and is committed to providing the safest, high-quality, high-value care for our patients. Through Choosing Wisely, the RCH is part of a worldwide campaign challenging clinicians to think differently about the way we provide care, and to challenge the status quo when what we might normally do is no longer adding value to patient outcomes.
The exit strategy for COVID-19 is a vaccine. To stop this pandemic we may need to vaccinate a significant proportion of the entire global population of 7 billion people. Where are we up to with vaccine development? Who gets vaccinated? How to communicate the benefits of a novel, fast tracked vaccine when misinformation is already spreading.
COVID-19 has resulted in a flurry of high-stakes decision-making, at a public health level and an individual patient level, with significant impacts on how children are cared for, and how staff work. Many of these decisions have ethical dimensions.
Blood-clotting complications are rapidly emerging as a significant part of the pathogenesis of COVID-19. There are reports of otherwise well people with COVID-10 having strokes, pulmonary emboli and heart attacks, and children with inflammation of their blood vessels. In recent weeks series of cases of a multi-system inflammatory condition, some resembling Kawasaki disease, have been reported in children in Europe, UK and USA.
COVID-19 is almost always a mild disease in children. Adults are much more likely to become very unwell or die than children. Why is this so?
Data from around the world consistently shows that COVID-19 is essentially a mild disease in children. However, the indirect effects of COVID-19 may have a more profound effect than the direct effects of the infection.
We will hear from 3 speakers on the global and clinical aspects, and the broader social, education and wellbeing impact of COVID-19 on children.
Electroencephalography (EEG) has a long history at The Royal Children’s Hospital. From its beginnings in the pre-imaging era as simple paper recordings of brain waves in children with various neurological disorders, EEG has evolved to a specialised discipline within neurophysiology, drawing on the many advances in clinical neurology, computerisation and neuroimaging.
Under the leadership of Paul F. Levy, the Beth Israel Deaconess Medical Center in Boston engaged in a program to eliminate preventable harm to patients, with a remarkable level of transparency to the public about the hospital’s progress towards that goal.
The question of long-term ventilation for children with progressive conditions, such as muscular dystrophy or metabolic disease, is one of the enduring puzzles in paediatric ethics. Is it ethical to put a child on invasive mechanical ventilation when they will never be able breathe again on their own, and will inevitably die from their condition?
